Background {#Sec1}
==========

Millions of people have burns every year in the world. Only in China, approximately 5000--10,000 peoples sustain burn injuries per 1 million, and 10% of them require medical intervention. Jiangxi province locates in southeastern region in China, and having numerous fireworks factories. Consequently, there are many thermal burns patients in local burn units, and millions of dollars having been consumed every year.

Skin is the first barrier of defense against microbial invasion, and it becomes more prone to infection once it gets burns. Many pathogens are responsible for burn wound infections, including *Staphylococcus* spp., *Enterococcus* spp., *Pseudomonas* spp., *Acinetobacter* spp., and fungi \[[@CR1]\]. However, *Staphylococcus aureus* (*S.aureus*) remains a leading cause of infections in burn centers \[[@CR2]\]. The emergence and transmission of methicillin-resistant *S. aureus* (MRSA) in burn centers results in some poor outcomes such as prolonged hospitalization, bacteremia or sepsis, even death, which require further prevention and treatment efforts \[[@CR3]\].

The main task for successful clinical treatment of microorganism infection depends on the knowledge of the characteristics of these infecting strains and their antibiotic susceptibility profiles. As a result, identification of the antibiotic susceptibility patterns of different strains in the burns center provides more appropriate treatments and decreased expenses. In addition to antibiotic resistance, another important factor that leads to treatment failure in burns patients is the production of different virulence factors. For example, these Panton-Valentine Leukocidin (PVL*)*-producing strains of *S. aureus* are associated with increased lethality compared to the PVL-negative strains \[[@CR4]\]. Skin and soft tissue infections (SSTIs) still have been taken as the primary source in burns patients \[[@CR5], [@CR6]\] and antibacterial ointment is usually taken as the mainstay of treatment, different from non-SSTIs patients who treated with injectable antibiotics in China. It is necessary to know different characteristics between SSTI and non-SSTI groups for empirical therapy at the early infectious stage.

Molecular typing of *S. aureus* is of significant value as a tool to control infection \[[@CR7]\]. At present, there are several molecular typing methods, including multilocus sequence typing (MLST), staphylococcal protein A (spa) typing, and staphylococcal cassette chromosome mec (SCCmec) typing. In general, a combination of typing methods could provide more detailed genetic linkage among these strains.

A high rate of isolated *S. aureus* corresponds to a high infectious level in burn centers \[[@CR1]--[@CR3]\]. However, there are few studies on the characterization of high isolated *S. aureus* from patients with burns in Jiangxi province, China. Many factors have action on effective treatment and control of *S. aureus* or MRSA infections. As a result, it is extremely important to know the different pattern of antimicrobial resistance and the prevalent clone of *S. aureus* or MRSA for local optimal clinical control.

Methods {#Sec2}
=======

Bacterial isolates {#Sec3}
------------------

This study included all clinical isolates submitted for culture and sensitivity test at the burn center of the First Affiliated Hospital of Nanchang University in China, from January 1, 2014s to December 31, 2015s. *S. aureus* isolates were identified by using the VITEK-2 compact (BioMérieux, France) GP colorimetric identification card. Resistance to oxacillin or cefoxitin was confirmed by VITEK-2 compact AST-GP67 (BioMérieux, France), with resistance defined as an oxacillin minimum inhibitory concentration (MIC) ≥ 4 μg/mL and cefoxitin MIC ≥8 μg/mL \[[@CR8]\]. In the case of multiple *S. aureus* isolates from the same patient, the first detected resistant specimen was included. In total, 125 *S. aureus* isolates were characterized, including 75 from SSTIs and 50 from non-SSTIs. The isolated strains stored at − 80 °C were thawed and sub-cultured on BHI medium prior to DNA extraction.

Antimicrobial susceptibility test (AST) {#Sec4}
---------------------------------------

In addition to oxacillin and cefoxitin, other antimicrobials listed for routine reporting of *S. aureus* were included for AST by using VITEK-2 compact AST-GP67 (BioMérieux, France) test card for Gram-positive susceptibility. Antibiotics used for susceptibility test included benzylpenicillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, erythromycin, clindamycin, quinupristin/dalfopristin, linezolid, vancomycin, tetracycline, tigecycline, nitrofurantoin, rifampicin, and trimethoprim/sulfamethoxazole. The MIC interpretive standard or breakpoint values were set following the guidelines of Clinical and Laboratory Standard Institute M100-S23. *S. aureus* ATCC25923 was used as a quality control for MIC detection.

Detection of toxin genes {#Sec5}
------------------------

Genomic DNA was extracted using a DNA extraction kit (Sangon Biotech, Shanghai) with lysostaphin, according to the manufacturer's instructions. Several clinically significant toxin genes were detected by PCR \[[@CR9], [@CR10]\], including *lukS/F-PV* (encoding Panton-Valentine leukocidin), *tst* (encoding toxic shock syndrome toxin 1), *sea*-*see* and *seg*-*sej* (encoding staphylococcal enterotoxins SEA-SEE and SEG-SEJ), and *HL*a-*HL*g (encoding staphylococcal hemolysin).

Detection of molecular types {#Sec6}
----------------------------

All *S. aureus* isolates were investigated by multilocus sequence typing (MLST), and the products of seven housekeeping gene fragments were sequenced (Sangon Biotech, Shanghai) and compared with allele profiles from *S. aureus* database ([www.mlst.net/](http://www.mlst.net/)). Spa and SCCmec typing of MRSA were performed as previously described \[[@CR2]\] .

Statistical analysis {#Sec7}
--------------------

The chi-square or Fisher's exact test was used as appropriate using the software package SAS 8.2 (SAS Institute Inc., Cary, NC, USA). A two-sided *P* value of \< 0.05 was considered statistically significant.

Results {#Sec8}
=======

Clinical data {#Sec9}
-------------

The median age of burns patients was 26 years and 7 months (range: 3 months - 79 years), as the sex distribution of male/female was 69/56 (55.2%/44.8%). All enrolled patients were from the burns center. The infectious source for burns patients included SSTI (75/125, 60.0%), respiratory tract (21/125, 16.8%), blood (14/125, 11.2%), and others (15/125, 12.0%).

Antimicrobial susceptibility test {#Sec10}
---------------------------------

Ninety-nine isolates (68 isolated from SSTIs and 31 from non-SSTIs) were confirmed as MRSA and 26 isolates (7 isolated from SSTIs and 19 from non-SSTIs) confirmed as methicillin-susceptible *S.aureus* (MSSA), respectively. All 125 isolates were susceptible to vancomycin, linezolid, daptomycin, and quinupristin/dalfopristin. 15 isolates (3 from SSTIs and 12 from non-SSTIs) were susceptible to penicillin. The antimicrobial susceptibilities of *S. aureus* isolated from SSTIs were almost equal to those from non-SSTIs. These findings were summarized in Table [1](#Tab1){ref-type="table"}.Table 1Antimicrobial susceptibility profile of *S. aureus*Antimicrobial*S.aureus* in SSTI (*n* = 75)*S.aureus* in non-SSTI (*n* = 50)R(%)I(%)S(%)R(%)I(%)S(%)Penicillin G93.30.06.784.00.016.0Cefoxitin Screen90.70.09.362.00.038.0Oxacillin88.00.012.060.00.040.0Gentamicin60.02.737.338.02.060.0Ciprofloxin62.72.734.664.02.034.0Levofloxacin42.71.356.052.04.044.0Moxifloxacin25.34.070.734.04.062.0Clindamycin78.72.718.654.02.044.0Erythromycin90.72.76.650.04.046.0Tetracycline72.01.326.750.02.048.0Rifampicin49.32.748.030.02.068.0Quinupristin/Dalfopristin0.00.0100.00.00.0100.0Trimethoprim/Sulfamethoxazole18.70.081.316.00.084.0Tigecycline1.30.098.72.00.098.0Nitrofurantoin0.00.0100.00.00.0100.0Linezolid0.00.0100.00.00.0100.0Vancomycin0.00.0100.00.00.0100.0*SSTI*, skin and soft tissue infection

Virulence factors {#Sec11}
-----------------

As shown in Table [2](#Tab2){ref-type="table"}, *seg* (54/125, 43.2%) was the most frequently detected enterotoxin gene, of which 21 isolated from SSTIs and 33 isolates were from non-SSTIs. 19 isolates showed presence of *lukS/F-PV*, including 15 SSTIs and 4 non-SSTIs. No *seh*-positive isolates were detected. Staphylococcal *HLa* and *HLg* were the most frequently detected hemolysin genes, occurring in 118 isolates. *S. aureus* isolates from SSTIs were more likely to carry *sea* and *seg* (*P* = 0.002 and 0.01, respectively), whereas non-SSTI patients were more likely to carry *seb* (*P* = 0.04).Table 2Prevalence of virulence genes from 125 *S. aureus* isolatesGenesTotal (*n* = 125)SSTI (*n* = 75)non SSTI (*n* = 50)*P* value*lukS/F-PV*191540.112sea163130.002seb191630.042sec3300.161sed5230.372see1100.415seg5421330.009seh1010.223sei2919100.583sej6330.626tst7520.547HLa11872460.871HLb5938210.567HLd9962370.689HLg11873450.766*SSTI*, skin and soft tissue infection; *lukS/F-PV*, gene encoding Panton-Valentine leukocidin; *sea-see* and *seg-sej*, gene encoding staphylococcal enterotoxins; *tst*, gene encoding toxic shock syndrome toxin 1; *HLa- HLg*, gene encoding staphylococcal hemolysin. *P*-value and two-sided *P*-value were calculated by the chi-square or Fisher's exact test appropriately

Molecular epidemiological characteristics {#Sec12}
-----------------------------------------

Among 125 *S. aureus* isolates, 21 sequence types (STs) and 27 spa types were acquired (Table [3](#Tab3){ref-type="table"}). We detected 4 SCCmec type I, 12 SCCmec type II, 61 SCCmec type III, 20 SCCmec IV, and 2 SCCmec type V. As shown in Fig. [1](#Fig1){ref-type="fig"}, MSSA isolates expressed greater diversity in molecular characteristics than MRSA; 43 clones were present in these isolates, including 10 shared clones.Table 3Distribution of major clones among 125 *S. aureus* isolatesCloneCCsTotalSSTIsNon- SSTIsVirulence genesST239-SCCmecIII-t030847388LukS/F-PV(11),Sea(6), seb(4), sed(3), seg(27), sei(16), sej(3), tst(2), HLa(46), HLb(22), HLd(46), HLg(46)ST239-SCCmecIII-t03781486LukS/F-PV(2),sea(2), seb(2),sed(1), seg(5), sei(3) sej(1), HLa (13), HLb(8), HLd(11), HLg(13)ST338-SCCmecIV-06259871sea(1), seb(3), sec(1), sei(2), seg(1), tst(2), HLa(8), HLb(3), HLd(6), HLg(7)ST5-SCCmecII-t00251248sea(4), sed(1), seg(8), sei(1), HLα(10), HLβ(4), HLγ(10), HLδ(11)ST59-SCCmecIV-t12759220seb(1),see(1), HLa(1), HLb(1),HLg(2)ST59- SCCmecIV-t43759330seb(1),tst(1), HLa(3), HLb(2), HLd(2), HLg(3)ST30-SCCmecI-t01930202seb(1), seg(2), HLa(2), HLb(1),HLd(1), HLg(2)ST30-SCCmecIV-t06230431sea(1), seb(3), sec(1), sej(1), HLa(2), HLb(2), HLd(2), HLg(3)ST88-SCCmecIV-t17288202LukS/F-PV(1), Seb(1), seg(1), HLa(2), HLb(1), HLd(2), HLg(2)ST398-SCCmecI-t034398211Luks/F-PV(1), Seb(1), sej(1), HLa(2), HLb(1), HLd(2), HLg(2)ST88-SCCmecV-t374088101Luks/F-PV(1), seg(1), HLa(1), HLb(1), HLg(1)ST45-SCCmecV-t108145101seg(1), HLa(1), HLb(1), HLg(1)ST88-IV-t00288110Seb(1), sec(1), HLa(1), HLb(1), HLg(1) Luks/F-PV(1),sea(1), sed(1), sei(1), tst(1), HLa(2), HLb(1)ST239-t308211HLd(2), HLg(2)ST25-t03725211Luks/F-PV(1), Seb(1), HLa(2), HLb(1), HLd(1), HLg(2)ST7-t0917202seg(2), sei(2), tst(1), HLa(2), HLb(1), HLd(2), HLg(2)ST5-t0025110sej(1), HLa(1), HLg(1)ST6-t7016101sea(1), seg(1),sei (2), HLa1), HLd(1), HLg(1)ST188-t318188110seg(2), sei(1), tst(1), HLa(1), HLb(1), HLd(1), HLg(1) LukS/F-PV(1), sea(1), seb(1), seh (1), HLa(2), HLb(1), HLd(1),ST59-t16359211HLg(2)ST30-t04530101tst(1), HLa(1), HLb(1), HLg(1)ST2898-t00530202sei(1), HLa(2), HLb(1), HLd(1), HLg(2)ST50-t18550101HLa(1), HLd(1), HLg(1)ST25-t07825111HLa(1), HLg(1)ST1-t1271211sea(1), HLa(2), HLb(1), HLd(1), HLg(1)ST2155-t1451121101tst(1), HLa(1), HLd(1), HLg(1)ST5-t0455101seg(1), HLa(1), HLb(1), HLd(1), HLg(1)ST398-t571398101seg(1), sej(1), HLa(1), HLb(1), HLd(1), HLg(1)ST152-t002152101sei(1), HLa(1), HLb(1), HLd(1), HLg(1)ST17-t374117101HLa(1), HLb(1), HLg(1)ST641641101seg(1), HLa(1), HLd(1), HLg(1)ST9-t8789110seg(1),HLa(1), HLg(1)ST45-t823245101HLa(1), HLd(1), HLg(1)SSTI, skin and soft tissue infectionFig. 1Distribution of major clones among 125 *S.aureus* isolates

Twenty sequence types (STs) from 13 clonal complexes (CCs) were identified among all 125 *S. aureus* isolates. The most common ST was ST239 (63/125, 50.4%), followed by ST5 (14/125, 11.2%), ST59 (7/125, 5.6%), and ST30 (7/125, 5.6%). ST239 was detected in 44 isolates from SSTIs and 19 isolates from non-SSTIs, and ST59 was found in 6 isolates from SSTIs and 1 isolate from non-SSTI. The distribution of *S. aureus* in ST239 and ST5 was significantly different between SSTIs and non-SSTIs (*P* = 0.057 or 0.006); however, there was no difference in the distribution of ST59 and ST30 between isolates from SSTI and non-SSTI groups (*P* = 0.174, 0.111). ST239 was the most common ST among *lukS/F-PV*-positive isolates, including 11 isolates (10 MRSA and 1 MSSA) from SSTIs and 8 isolates (6 MRSA and 2 MSSA) from non-SSTIs. The other STs in *lukS/F-PV*-positive isolates were ST88 (2 MRSA), ST25 (1 MRSA), and ST398 (1 MRSA).

The different 26 spa type was identified in this study. t30 (49/125, 39.2%) was the most common spa type, followed by t037 (16/125, 12.8%) and t062 (14/125, 11.2%). t30 was detected in 39 isolates from SSTIs and in 10 isolates from non-SSTIs, and t037 was detected in 9 isolates from SSTIs and 7 isolates from non-SSTIs. The former displayed a significant difference between isolates from SSTIs or non-SSTIs (*P* = 0.014), while the latter did not (*P* = 0.774).

Discussion {#Sec13}
==========

As a clinically important pathogen, *S. aureus* can cause many kinds of infections, such as SSTI, sepsis, pneumonia, and abscesses. As shown in the results section, there were 75 SSTIs, 14 blood or other bodily fluids, and 21 respiratory infection samples from *S. aureus* infected patients. Additionally, 68 isolates (15 community-acquired MRSA (CA-MRSA) and 53 hospital-acquired MRSA (HA-MRSA)) were obtained from SSTIs and 31 isolates (6 CA-MRSA and 25 HA-MRSA) from non-SSTIs. There was no significant difference between SSTI and non-SSTI groups in the occurrence of MRSA (*P* = 0.179). However, as shown in Table [1](#Tab1){ref-type="table"}, *S.aureus* had higher resistance to erythromycin in SSTIs than that from non-SSTIs (*P* = 0.02), probably due to a high level of MRSA infection, which commonly integrates some important resistance genes \[[@CR11]\]. Since its emergence in 1995 in Brazil, prevalence of ST239 has led to a high occurrence of hospital-acquired infection globally \[[@CR12]\], as witnessed by *S. aureus* clone outbreaks in China, Africa, Australia, and America \[[@CR13]--[@CR15]\]. In this study, ST239 was found to be the most prevalent clone in the burn center (50.4%, 63/125), which is consistent to reports that ST239 is the most common clone in mainland China \[[@CR16]\]. ST239 is usually associated with SSTIs disease \[[@CR17]\], as a result, it was in expectation that patients with SSTIs had a higher proportion of infection caused by the ST239 clone than patients with non-SSTIs (*P* = 0.048). ST239 is mainly associated with staphylococcal cassette chromosome mec type III (ST239-SCCmecIII) \[[@CR18]\]. As shown in Table [3](#Tab3){ref-type="table"}, this study demonstrated evidence that more than half of the isolates from SSTIs were ST239-SCCmecIII-t030 or ST239-SCCmecIII-t037, and this number was higher than those isolates from non-SSTIs. ST239-SCCmecIII-t037 is closely related with ST239-SCCmecIII-t030, as the former is considered an ancestral ST239 spa type and has been gradually replaced by ST239-SCCmecIII-t030 in many places \[[@CR19], [@CR20]\]. ST5, found characterized in a total of 12 MRSA and 2 MSSA isolates, was the second most common ST in our study. ST5 has also been found to be among the most common genotype isolated from children with cystic fibrosis (CF) or nasal carriage \[[@CR21], [@CR22]\].

Comprehensively considered high antibiotic resistance and high virulence, some isolated *S. aureus* were a dangerous pathogen in this study. The harmfulness of *S. aureus* is partially determined by a series of virulence factors, which vary significantly according to different strains. As a result, to acquire valuable epidemiologic control in an endemic area, it is necessary to know the distribution of some important virulence factors. Staphylococcal enterotoxins (SEs) include a series of virulent factors associated with a severe disease, which usually causes food poisoning. SEs may suppress the motility of the human polymorphonuclear neutrophils through the inhibition of exoprotein expression, and allow *S. aureus* to invade and damage tissues. Although previous studies have confirmed that *sea* and *seb* are the most abundant toxin genes in clinical *S. aureus* isolates from patients in China \[[@CR23]\], *seg* was the predominant SE gene detected in current study. There was significant difference observed between isolates from SSTIs and non-SSTIs (*P* = 0.009), which might represent regional characteristics. The study confirms that isolates from SSTIs predominantly carry *seb* (*P* = 0.042), which has been proved to be a hallmark of CA-MRSA \[[@CR24]\]. There are four hemolysin genes in *S. aureus*, with the roles of which usually lead to the release of bacteriolytic enzyme that damages the surrounding cells by inhibiting blood cell function. HLa and HLb are the main toxins inducing pathological injury. Consistent with the report in Wenzhou, China \[[@CR25]\], HLa, HLb, HLd, and HLg were all been detected in this study. These findings indicated that a high level of HLa, HLb, HLd, and HLg genes could be considered characteristic of MRSA strains in this region. There was no difference between isolates from SSTIs and non-SSTIs in these genes (*P* = 0.567--0.871, respectively). *LukS/F-PV* encodes Panton-Valentine leukocidin, an important virulent factor which usually damages neutrophils and is associated with SSTIs \[[@CR26]\]. There is no connection between PVL-positive isolates among *S. aureus* isolated from SSTIs and those from non-SSTIs (*P* = 0.112), mostly because these strains originate from SSTIs.

Conclusion {#Sec14}
==========

Our study indicated that the infectious rate of MRSA was high in burns center and SSTIs had higher resistant levels than non-SSTIs. Additionally, SSTIs have different virulent factors profiles compared with non-SSTIs. The most prevalent clone was ST239-SCCmecIII- t030 in the burn center.

CLSI

:   Clinical and Laboratory Standards Institute

MRSA

:   Methicillin-resistant *S.aureus*
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:   Staphylococcal cassette chromosome mec

SSTI

:   Skin and soft tissue infection
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